Bosentan Tablets for Oral Suspension are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital ...
Men's wellness has long been an underserved area in the health and fitness industry, often overshadowed by the more visible conversations around women's health. This gendered gap has allowed mental ...
Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for ...
Taiyo Yuden will benefit from increased passive components per phone as a result of advancing technology in telecommunications. In particular, diffusion of LTE and LTE-advanced networks and phones ...